BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Tapestry Pharmaceuticals

Tapestry Pharmaceuticals, Inc. is a company focused on developing proprietary therapies for the treatment of cancer. We are also actively engaged in evaluating new therapeutic agents and related technologies for in-licensing. Tapestry's technical expertise is our ability to identify, chemically alter and produce novel therapeutic compounds derived from natural product sources. Tapestry has developed a novel third generation taxane, TPI 287. In December 2004 we filed an IND application, and on January 21, 2005, we were cleared to proceed with clinical trials by the FDA. We commenced Phase I clinical trials of TPI 287 in May 2005 with an every 7 day dosing (“Q7D”) study, and in January 2006, we commenced a second Phase I study with an alternative every 3 week dosing (“Q21D”) regimen.


Contact Details:
4840 Pearl East Circle, 300W
Boulder
CO
80301-2408
United States of America
Tel:303 516 8500
Fax:303 530 1296
Email:info@tapestrypharma.com
WWW:

www.tapestrypharma.com/




Loading...

Recent Publications by Tapestry Pharmaceuticals:

Plant natural products: back to the future or into extinction?
Natural product substances have historically served as the most...
28th September, 2007
Tapestry Pharmaceuticals, Inc., 4840 Pearl East Cir. #300W, Boulder, CO Phytochemistry. 2007 Jul;68(14):2015-22. Epub 2007 Jun 14.
DOI Direct Link

BioNews Results for Tapestry Pharmaceuticals:

TAPESTRY PHARMACEUTICALS INC EPS Estimated At -0.65: Current Recommendation is Market Outperform
Calibre Macro World:  Aug 29 2008 8:40PM Matching: tapestry pharmaceuticals
Advanced Cancer Therapeutics names new CSO
Pharmaceutical Business Review:  Aug 21 2008 6:15AM Matching: tapestry pharmaceuticals
Advanced Cancer Therapeutics Appoints Gilles Tapolsky, Ph.D. to Chief Scientific Officer
Pharma Live:  Aug 19 2008 11:43AM Matching: tapestry pharmaceuticals

Tapestry Pharmaceuticals Patents:

US Patent No.Title
7153946 Molecular conjugates for use in treatment of cancer
6825166 Molecular conjugates for use in treatment of cancer

Tapestry Pharmaceuticals (TPPH) Financial information Links from Barchart

TPPH Quote from from Barchart.com
TPPH Chart from from Barchart.com
TPPH Profile from from Barchart.com
TPPH Opinion from from Barchart.com

View more Tapestry Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 227 times since April 2007, the link to the organisation's website has been followed 46 times

Recent Search Terms used to find this page: tapestry pharmaceuticals bankruptcy | Tapestry pharmaceutical bankruptcy | tapestry patent 4840 | Tapestry Pharmaceuticals | tapestry pharmaceuticals | TAPESTRY PHARMACEUTICALS LTD | .

Search for more companies in Boulder

Search for more companies in CO



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Tapestry Pharmaceuticals
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.